Trial intelligence / Profile preview

Ziprasidone in Pediatric Bipolar I Disorder

NCT00257166Phase 3Completed

Sponsor
Viatris
Start
Jan 2006
Primary completion
Jul 2007
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of ziprasidone in bipolar I disorder, sponsored by Viatris. Started Jan 2006; status: completed.

02

Drugs

ziprasidone
03

Conditions

bipolar I disorder

Beyond the preview

Go deeper on NCT00257166.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00257166.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call